TERIPARATIDE | A213641 | AMPHASTAR PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| S.D. Ind. | 2021-06-29 | Terminated 2021-10-01 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$536.55
per ml
Lowest NADAC/Unit
$536.55
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00548231100TERIPARATIDE 560 MCG/2.24 ML PEN | $536.55 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.